| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.02e-05 | 206 | 14 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 2.05e-05 | 10 | 14 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 5.71e-04 | 51 | 14 | 2 | GO:0001784 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 1.04e-03 | 69 | 14 | 2 | GO:0045309 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 2.96e-03 | 117 | 14 | 2 | GO:0051219 | |
| GeneOntologyBiologicalProcess | ureteric peristalsis | 1.69e-06 | 3 | 16 | 2 | GO:0072105 | |
| GeneOntologyBiologicalProcess | ureter smooth muscle contraction | 1.69e-06 | 3 | 16 | 2 | GO:0014849 | |
| GeneOntologyBiologicalProcess | mammary placode formation | 3.38e-06 | 4 | 16 | 2 | GO:0060596 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle phase transition | 3.47e-06 | 140 | 16 | 4 | GO:1901989 | |
| GeneOntologyBiologicalProcess | atrioventricular canal morphogenesis | 5.63e-06 | 5 | 16 | 2 | GO:1905222 | |
| GeneOntologyBiologicalProcess | cardiac jelly development | 8.45e-06 | 6 | 16 | 2 | GO:1905072 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 1.07e-05 | 407 | 16 | 5 | GO:0045787 | |
| GeneOntologyBiologicalProcess | mammary gland formation | 2.02e-05 | 9 | 16 | 2 | GO:0060592 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle G1/S phase transition | 3.03e-05 | 80 | 16 | 3 | GO:1902808 | |
| GeneOntologyBiologicalProcess | atrioventricular canal development | 5.11e-05 | 14 | 16 | 2 | GO:0036302 | |
| GeneOntologyBiologicalProcess | urinary tract smooth muscle contraction | 5.89e-05 | 15 | 16 | 2 | GO:0014848 | |
| GeneOntologyBiologicalProcess | peristalsis | 5.89e-05 | 15 | 16 | 2 | GO:0030432 | |
| GeneOntologyBiologicalProcess | ectodermal placode morphogenesis | 6.73e-05 | 16 | 16 | 2 | GO:0071697 | |
| GeneOntologyBiologicalProcess | ectodermal placode formation | 6.73e-05 | 16 | 16 | 2 | GO:0060788 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 7.61e-05 | 307 | 16 | 4 | GO:0090068 | |
| GeneOntologyBiologicalProcess | ectodermal placode development | 8.57e-05 | 18 | 16 | 2 | GO:0071696 | |
| GeneOntologyBiologicalProcess | muscle cell fate commitment | 8.57e-05 | 18 | 16 | 2 | GO:0042693 | |
| GeneOntologyBiologicalProcess | response to magnesium ion | 1.67e-04 | 25 | 16 | 2 | GO:0032026 | |
| GeneOntologyBiologicalProcess | Fc-epsilon receptor signaling pathway | 1.67e-04 | 25 | 16 | 2 | GO:0038095 | |
| GeneOntologyBiologicalProcess | phasic smooth muscle contraction | 2.42e-04 | 30 | 16 | 2 | GO:0014821 | |
| GeneOntologyBiologicalProcess | endocardial cushion formation | 2.76e-04 | 32 | 16 | 2 | GO:0003272 | |
| GeneOntologyBiologicalProcess | endocardial cushion morphogenesis | 5.24e-04 | 44 | 16 | 2 | GO:0003203 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 5.55e-04 | 516 | 16 | 4 | GO:1901987 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 8.37e-04 | 246 | 16 | 3 | GO:1902806 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 9.09e-04 | 58 | 16 | 2 | GO:0003197 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 1.04e-03 | 62 | 16 | 2 | GO:0038093 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 1.07e-03 | 615 | 16 | 4 | GO:0002764 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 1.07e-03 | 1085 | 16 | 5 | GO:0050776 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 1.14e-03 | 65 | 16 | 2 | GO:0072132 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 1.14e-03 | 65 | 16 | 2 | GO:0060443 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | 1.15e-03 | 627 | 16 | 4 | GO:0044770 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 1.36e-03 | 291 | 16 | 3 | GO:0072593 | |
| GeneOntologyBiologicalProcess | response to wounding | 1.38e-03 | 659 | 16 | 4 | GO:0009611 | |
| GeneOntologyBiologicalProcess | heart looping | 1.44e-03 | 73 | 16 | 2 | GO:0001947 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 1.47e-03 | 74 | 16 | 2 | GO:0042733 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 1.57e-03 | 306 | 16 | 3 | GO:0044843 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 1.68e-03 | 79 | 16 | 2 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 1.72e-03 | 80 | 16 | 2 | GO:0003143 | |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 1.74e-03 | 317 | 16 | 3 | GO:0002699 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 2.06e-03 | 1256 | 16 | 5 | GO:0051726 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 2.08e-03 | 338 | 16 | 3 | GO:0045165 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 2.12e-03 | 89 | 16 | 2 | GO:2000379 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 2.12e-03 | 89 | 16 | 2 | GO:0060411 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 2.19e-03 | 747 | 16 | 4 | GO:0007169 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 2.37e-03 | 94 | 16 | 2 | GO:0003151 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway | 2.57e-03 | 98 | 16 | 2 | GO:0008543 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 2.62e-03 | 99 | 16 | 2 | GO:0051145 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 2.83e-03 | 103 | 16 | 2 | GO:0035050 | |
| GeneOntologyBiologicalProcess | roof of mouth development | 2.89e-03 | 104 | 16 | 2 | GO:0060021 | |
| GeneOntologyBiologicalProcess | response to axon injury | 2.94e-03 | 105 | 16 | 2 | GO:0048678 | |
| MousePheno | short face | 1.26e-04 | 17 | 14 | 2 | MP:0030066 | |
| MousePheno | abnormal facial morphology | 1.43e-04 | 910 | 14 | 6 | MP:0003743 | |
| MousePheno | cleft palate | 1.52e-04 | 289 | 14 | 4 | MP:0000111 | |
| MousePheno | oral cleft | 1.56e-04 | 291 | 14 | 4 | MP:0021164 | |
| MousePheno | abnormal palate morphology | 2.28e-04 | 321 | 14 | 4 | MP:0003755 | |
| MousePheno | increased transitional stage B cell number | 2.76e-04 | 25 | 14 | 2 | MP:0008189 | |
| MousePheno | abnormal limb morphology | 2.80e-04 | 1028 | 14 | 6 | MP:0002109 | |
| MousePheno | microphthalmia | 3.60e-04 | 362 | 14 | 4 | MP:0001297 | |
| MousePheno | abnormal vagina orifice morphology | 3.99e-04 | 30 | 14 | 2 | MP:0001142 | |
| MousePheno | abnormal eye size | 4.12e-04 | 375 | 14 | 4 | MP:0002697 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 4.38e-04 | 381 | 14 | 4 | MP:0003857 | |
| MousePheno | abnormal head morphology | 4.47e-04 | 1120 | 14 | 6 | MP:0000432 | |
| MousePheno | small face | 6.08e-04 | 37 | 14 | 2 | MP:0030064 | |
| MousePheno | abnormal face size | 7.84e-04 | 42 | 14 | 2 | MP:0030063 | |
| MousePheno | limbs/digits/tail phenotype | 8.36e-04 | 1258 | 14 | 6 | MP:0005371 | |
| MousePheno | increased immature B cell number | 8.60e-04 | 44 | 14 | 2 | MP:0008214 | |
| MousePheno | abnormal vagina morphology | 1.15e-03 | 51 | 14 | 2 | MP:0001139 | |
| MousePheno | decreased CD8-positive, naive alpha-beta T cell number | 1.20e-03 | 52 | 14 | 2 | MP:0013435 | |
| MousePheno | craniofacial phenotype | 1.33e-03 | 1372 | 14 | 6 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 1.33e-03 | 1372 | 14 | 6 | MP:0000428 | |
| MousePheno | increased effector memory CD8-positive, alpha-beta T cell number | 1.54e-03 | 59 | 14 | 2 | MP:0010850 | |
| MousePheno | impaired natural killer cell mediated cytotoxicity | 1.87e-03 | 65 | 14 | 2 | MP:0005070 | |
| MousePheno | abnormal transitional stage B cell morphology | 1.87e-03 | 65 | 14 | 2 | MP:0008188 | |
| MousePheno | abnormal limb long bone morphology | 1.95e-03 | 568 | 14 | 4 | MP:0011504 | |
| MousePheno | abnormal CD8-positive, naive alpha-beta T cell number | 1.98e-03 | 67 | 14 | 2 | MP:0013434 | |
| MousePheno | abnormal heart tube morphology | 2.04e-03 | 68 | 14 | 2 | MP:0000270 | |
| MousePheno | abnormal hindlimb morphology | 2.05e-03 | 576 | 14 | 4 | MP:0000556 | |
| MousePheno | abnormal nasal bone morphology | 2.10e-03 | 69 | 14 | 2 | MP:0000102 | |
| MousePheno | abnormal effector memory CD8-positive, alpha-beta T cell number | 2.10e-03 | 69 | 14 | 2 | MP:0010849 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 2.17e-03 | 268 | 14 | 3 | MP:0011108 | |
| MousePheno | abnormal limb bone morphology | 2.20e-03 | 587 | 14 | 4 | MP:0002115 | |
| MousePheno | abnormal natural killer cell mediated cytotoxicity | 2.23e-03 | 71 | 14 | 2 | MP:0011719 | |
| MousePheno | short tibia | 2.31e-03 | 274 | 14 | 3 | MP:0002764 | |
| Domain | TBX | 6.02e-07 | 2 | 15 | 2 | IPR022582 | |
| Domain | TBX | 6.02e-07 | 2 | 15 | 2 | PF12598 | |
| Domain | TF_T-box | 8.13e-05 | 17 | 15 | 2 | IPR001699 | |
| Domain | TBOX_3 | 8.13e-05 | 17 | 15 | 2 | PS50252 | |
| Domain | TBOX | 8.13e-05 | 17 | 15 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 8.13e-05 | 17 | 15 | 2 | IPR018186 | |
| Domain | T-box | 8.13e-05 | 17 | 15 | 2 | PF00907 | |
| Domain | - | 8.13e-05 | 17 | 15 | 2 | 2.60.40.820 | |
| Domain | TBOX_1 | 8.13e-05 | 17 | 15 | 2 | PS01283 | |
| Domain | TBOX_2 | 8.13e-05 | 17 | 15 | 2 | PS01264 | |
| Domain | p53-like_TF_DNA-bd | 8.10e-04 | 53 | 15 | 2 | IPR008967 | |
| Domain | SH2 | 2.90e-03 | 101 | 15 | 2 | PF00017 | |
| Domain | SH2 | 3.43e-03 | 110 | 15 | 2 | SM00252 | |
| Domain | SH2 | 3.49e-03 | 111 | 15 | 2 | PS50001 | |
| Domain | SH2 | 3.56e-03 | 112 | 15 | 2 | IPR000980 | |
| Domain | - | 3.56e-03 | 112 | 15 | 2 | 3.30.505.10 | |
| Domain | SH3_1 | 7.46e-03 | 164 | 15 | 2 | PF00018 | |
| Domain | SH3 | 1.27e-02 | 216 | 15 | 2 | PS50002 | |
| Domain | SH3 | 1.27e-02 | 216 | 15 | 2 | SM00326 | |
| Domain | SH3_domain | 1.31e-02 | 220 | 15 | 2 | IPR001452 | |
| Domain | PH | 1.41e-02 | 229 | 15 | 2 | PF00169 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.33e-04 | 19 | 13 | 2 | M47733 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 2.33e-04 | 25 | 13 | 2 | M27865 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 2.39e-04 | 137 | 13 | 3 | M5669 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 3.37e-04 | 154 | 13 | 3 | M39007 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 4.59e-04 | 35 | 13 | 2 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 4.59e-04 | 35 | 13 | 2 | M773 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 4.86e-04 | 36 | 13 | 2 | M1315 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 6.00e-04 | 40 | 13 | 2 | M39695 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 7.94e-04 | 46 | 13 | 2 | MM15837 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 7.94e-04 | 46 | 13 | 2 | M8626 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 7.94e-04 | 46 | 13 | 2 | M27151 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.05e-03 | 53 | 13 | 2 | MM15716 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.26e-03 | 58 | 13 | 2 | MM14914 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.30e-03 | 59 | 13 | 2 | M39350 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.35e-03 | 60 | 13 | 2 | MM14913 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 2.10e-03 | 75 | 13 | 2 | M5436 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 2.32e-03 | 79 | 13 | 2 | M11816 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 2.75e-03 | 86 | 13 | 2 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 2.75e-03 | 86 | 13 | 2 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 2.81e-03 | 87 | 13 | 2 | M27205 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 3.41e-03 | 96 | 13 | 2 | M16121 | |
| Pathway | WP_B_CELL_RECEPTOR_SIGNALING | 3.48e-03 | 97 | 13 | 2 | M39323 | |
| Pubmed | Complex functional redundancy of Tbx2 and Tbx3 in mouse limb development. | 1.98e-07 | 2 | 16 | 2 | 35506352 | |
| Pubmed | The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer. | 1.98e-07 | 2 | 16 | 2 | 23624936 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 23388722 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 30223900 | ||
| Pubmed | Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. | 1.98e-07 | 2 | 16 | 2 | 17215859 | |
| Pubmed | Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | 1.98e-07 | 2 | 16 | 2 | 12185535 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 10468588 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 25394776 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 25371204 | ||
| Pubmed | Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. | 1.98e-07 | 2 | 16 | 2 | 11086080 | |
| Pubmed | Expression of Drosophila omb-related T-box genes in the developing human and mouse neural retina. | 5.95e-07 | 3 | 16 | 2 | 11726608 | |
| Pubmed | Promoter variants of KIR2DL5 add to diversity and may impact gene expression. | 5.95e-07 | 3 | 16 | 2 | 18461314 | |
| Pubmed | Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. | 5.95e-07 | 3 | 16 | 2 | 8988164 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 12000749 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 9196325 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 11748239 | ||
| Pubmed | Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes. | 5.95e-07 | 3 | 16 | 2 | 20025935 | |
| Pubmed | 9.75e-07 | 43 | 16 | 3 | 36878279 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 22284968 | ||
| Pubmed | Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections. | 1.19e-06 | 4 | 16 | 2 | 22652695 | |
| Pubmed | KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. | 1.19e-06 | 4 | 16 | 2 | 10820258 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 8798150 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 18362175 | ||
| Pubmed | Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. | 1.19e-06 | 4 | 16 | 2 | 18829543 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 10744659 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 12411320 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 17932569 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 18498296 | ||
| Pubmed | The membrane skeleton controls diffusion dynamics and signaling through the B cell receptor. | 1.98e-06 | 5 | 16 | 2 | 20171124 | |
| Pubmed | Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. | 1.98e-06 | 5 | 16 | 2 | 15456756 | |
| Pubmed | Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. | 1.98e-06 | 5 | 16 | 2 | 8853987 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 22002537 | ||
| Pubmed | Mouse thromboxane A2 receptor: cDNA cloning, expression and northern blot analysis. | 1.98e-06 | 5 | 16 | 2 | 1375456 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 17173667 | ||
| Pubmed | Lack of genetic interaction between Tbx20 and Tbx3 in early mouse heart development. | 2.97e-06 | 6 | 16 | 2 | 23936153 | |
| Pubmed | Uncoupling Sonic hedgehog control of pattern and expansion of the developing limb bud. | 2.97e-06 | 6 | 16 | 2 | 18410737 | |
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 15187135 | ||
| Pubmed | Evolution of mouse T-box genes by tandem duplication and cluster dispersion. | 2.97e-06 | 6 | 16 | 2 | 8878690 | |
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 16222716 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 10981967 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 23661717 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 22203979 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 23499492 | ||
| Pubmed | Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. | 4.16e-06 | 7 | 16 | 2 | 16556915 | |
| Pubmed | Expression of Tbx2 and Tbx3 in the developing hypothalamic-pituitary axis. | 4.16e-06 | 7 | 16 | 2 | 18534921 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 9503012 | ||
| Pubmed | Dynamic expression of Tbx2 and Tbx3 in developing mouse pancreas. | 5.55e-06 | 8 | 16 | 2 | 21867776 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 7920656 | ||
| Pubmed | Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. | 5.55e-06 | 8 | 16 | 2 | 11390470 | |
| Pubmed | Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system. | 8.91e-06 | 10 | 16 | 2 | 22223620 | |
| Pubmed | Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43. | 8.91e-06 | 10 | 16 | 2 | 18285513 | |
| Pubmed | 8.91e-06 | 10 | 16 | 2 | 17519333 | ||
| Pubmed | 8.91e-06 | 10 | 16 | 2 | 25487574 | ||
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 17668378 | ||
| Pubmed | Tbx Genes Specify Posterior Digit Identity through Shh and BMP Signaling. | 1.09e-05 | 11 | 16 | 2 | 14723846 | |
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 22683124 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 1.09e-05 | 11 | 16 | 2 | 8954725 | |
| Pubmed | The molecular basis of Pallister Hall associated polydactyly. | 1.31e-05 | 12 | 16 | 2 | 17588959 | |
| Pubmed | ISL1 regulates lung branching morphogenesis via Shh signaling pathway. | 1.31e-05 | 12 | 16 | 2 | 37442233 | |
| Pubmed | Expression of Slit and Robo genes in the developing mouse heart. | 1.54e-05 | 13 | 16 | 2 | 20941780 | |
| Pubmed | 1.54e-05 | 13 | 16 | 2 | 19120281 | ||
| Pubmed | 1.54e-05 | 13 | 16 | 2 | 25599332 | ||
| Pubmed | 1.54e-05 | 13 | 16 | 2 | 12668638 | ||
| Pubmed | Loss of Tbx2 delays optic vesicle invagination leading to small optic cups. | 1.80e-05 | 14 | 16 | 2 | 19576202 | |
| Pubmed | 1.80e-05 | 14 | 16 | 2 | 18467625 | ||
| Pubmed | Twist1 activity thresholds define multiple functions in limb development. | 2.08e-05 | 15 | 16 | 2 | 20732316 | |
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 25453830 | ||
| Pubmed | Lack of Genetic Interaction between Tbx18 and Tbx2/Tbx20 in Mouse Epicardial Development. | 2.37e-05 | 16 | 16 | 2 | 27253890 | |
| Pubmed | 2.37e-05 | 16 | 16 | 2 | 27856909 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 2.37e-05 | 16 | 16 | 2 | 16403292 | |
| Pubmed | 2.37e-05 | 16 | 16 | 2 | 21266775 | ||
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 15459098 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 2.69e-05 | 17 | 16 | 2 | 20878400 | |
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 2.69e-05 | 17 | 16 | 2 | 19218127 | |
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 20650299 | ||
| Pubmed | The del22q11.2 candidate gene Tbx1 regulates branchiomeric myogenesis. | 2.69e-05 | 17 | 16 | 2 | 15385444 | |
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 19450876 | ||
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 19761533 | ||
| Pubmed | 3.02e-05 | 18 | 16 | 2 | 27720610 | ||
| Pubmed | 3.02e-05 | 18 | 16 | 2 | 20200544 | ||
| Pubmed | Loss of Tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois. | 3.02e-05 | 18 | 16 | 2 | 12736212 | |
| Pubmed | TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration. | 3.02e-05 | 18 | 16 | 2 | 36941669 | |
| Pubmed | 3.02e-05 | 18 | 16 | 2 | 20386744 | ||
| Pubmed | 3.02e-05 | 18 | 16 | 2 | 22116936 | ||
| Pubmed | Isl1Cre reveals a common Bmp pathway in heart and limb development. | 3.38e-05 | 19 | 16 | 2 | 16556916 | |
| Pubmed | TBX2-positive cells represent a multi-potent mesenchymal progenitor pool in the developing lung. | 3.38e-05 | 19 | 16 | 2 | 31870435 | |
| Pubmed | Tbx2 terminates shh/fgf signaling in the developing mouse limb bud by direct repression of gremlin1. | 3.75e-05 | 20 | 16 | 2 | 23633963 | |
| Pubmed | 3.75e-05 | 20 | 16 | 2 | 20426625 | ||
| Pubmed | MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome. | 3.75e-05 | 20 | 16 | 2 | 22921202 | |
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 3.75e-05 | 20 | 16 | 2 | 20193031 | |
| Pubmed | 4.15e-05 | 21 | 16 | 2 | 36941249 | ||
| Pubmed | 4.15e-05 | 21 | 16 | 2 | 30292786 | ||
| Pubmed | 4.15e-05 | 21 | 16 | 2 | 16207751 | ||
| Pubmed | 4.56e-05 | 22 | 16 | 2 | 15843407 | ||
| Pubmed | 4.56e-05 | 22 | 16 | 2 | 20492596 | ||
| Pubmed | 4.99e-05 | 23 | 16 | 2 | 38828908 | ||
| Pubmed | Tbx2 and Tbx3 regulate cell fate progression of the otic vesicle for inner ear development. | 4.99e-05 | 23 | 16 | 2 | 36521641 | |
| Pubmed | The formation of the thumb requires direct modulation of Gli3 transcription by Hoxa13. | 5.44e-05 | 24 | 16 | 2 | 31896583 | |
| Pubmed | 5.44e-05 | 24 | 16 | 2 | 20624904 | ||
| Pubmed | 5.44e-05 | 24 | 16 | 2 | 18723448 | ||
| Cytoband | 19p13.3 | 3.04e-03 | 237 | 16 | 2 | 19p13.3 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 7.25e-05 | 18 | 13 | 2 | 620 | |
| GeneFamily | T-boxes | 7.25e-05 | 18 | 13 | 2 | 766 | |
| GeneFamily | SH2 domain containing | 2.32e-03 | 101 | 13 | 2 | 741 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.44e-05 | 336 | 14 | 4 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 5.53e-05 | 116 | 14 | 3 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.50e-05 | 134 | 14 | 3 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 2.48e-04 | 498 | 14 | 4 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 3.03e-04 | 206 | 14 | 3 | JC_fibro_500_K3 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | 3.13e-04 | 994 | 14 | 5 | PCBC_ratio_EB_vs_SC_1000 | |
| CoexpressionAtlas | e10.5_ColumEpith_Mandib_top-relative-expression-ranked_500_4 | 3.97e-04 | 226 | 14 | 3 | Facebase_ST1_e10.5_ColumEpith_Mandib_500_4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.13e-04 | 229 | 14 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.71e-04 | 256 | 14 | 3 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 162 | 14 | 3 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 162 | 14 | 3 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 162 | 14 | 3 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 170 | 14 | 3 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 173 | 14 | 3 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-05 | 173 | 14 | 3 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.04e-05 | 175 | 14 | 3 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 14 | 3 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 14 | 3 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 14 | 3 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | Striatum-Endothelial-MURAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.18e-05 | 179 | 14 | 3 | 3d58babf44e47462c3d4129dd2e94a2339fd7ce0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.18e-05 | 179 | 14 | 3 | 99167ac678cae5c35b1d4f4a81b32000437c00c2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-05 | 181 | 14 | 3 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-05 | 181 | 14 | 3 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-05 | 185 | 14 | 3 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.49e-05 | 187 | 14 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 2.49e-05 | 187 | 14 | 3 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.65e-05 | 191 | 14 | 3 | 14b11244c330cc4fe897253aaaf0df80caa01a55 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-05 | 192 | 14 | 3 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.69e-05 | 192 | 14 | 3 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | E15.5-Mesenchymal|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.73e-05 | 193 | 14 | 3 | 22a9f5b61f197757f72840b9cb849cdb20430e72 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 195 | 14 | 3 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.86e-05 | 196 | 14 | 3 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-early|World / Primary Cells by Cluster | 2.86e-05 | 196 | 14 | 3 | dd3c6ea5e4ebcc27064f16507de6db6dc8f86fa8 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.86e-05 | 196 | 14 | 3 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-early-1|World / Primary Cells by Cluster | 2.86e-05 | 196 | 14 | 3 | 70fe6a1a6de891832aaa6276c985b326985e14db | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-05 | 196 | 14 | 3 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-05 | 197 | 14 | 3 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-05 | 197 | 14 | 3 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-05 | 198 | 14 | 3 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 199 | 14 | 3 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-05 | 200 | 14 | 3 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | wk_08-11-Mesenchymal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.04e-05 | 200 | 14 | 3 | 91416639e69621c5b36eebf061d81bccfe66f135 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.04e-05 | 200 | 14 | 3 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 54 | 14 | 2 | 7816e6541e3a9e702f25bd102a95ce963ce31535 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 54 | 14 | 2 | 68c762094ea29e321a6fd4f6d9b598431023fa7b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.19e-04 | 109 | 14 | 2 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.50e-04 | 122 | 14 | 2 | c16110934172f174f4aefe14b81abce8514b30f0 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell-Peri|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.50e-04 | 122 | 14 | 2 | 006ac4f6807e688554d36557d29d5e5a0bc3c36f | |
| ToppCell | droplet-Skin-nan-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 122 | 14 | 2 | 8f675dc341b3f6e22f7e52c34d167d9e37df0982 | |
| ToppCell | frontal_cortex-Non-neuronal-pericyte_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.50e-04 | 122 | 14 | 2 | f3d9a5893fdee3562880fb6fc132b88169a7d997 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-04 | 122 | 14 | 2 | c7e81504e62d132624ec15b7d38dc5b6493a37a4 | |
| ToppCell | droplet-Skin-nan-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-04 | 125 | 14 | 2 | 5a309ce803d2b8efd791eb21808121bf5fc3ea8e | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.04e-04 | 127 | 14 | 2 | 0750743574c2fca8df07e11d73e8b94579209609 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 127 | 14 | 2 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-04 | 131 | 14 | 2 | d706405453408fbcfcabb1c7702b80f9e649ffca | |
| ToppCell | P07-Hematopoietic|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.30e-04 | 138 | 14 | 2 | fb8038393c2b88eb29bd23574c0c6178644900be | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-04 | 139 | 14 | 2 | 2fdc8f36510aff24abbc79ef2a842db75a85f946 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.42e-04 | 139 | 14 | 2 | 5970a654c64e3b54f9d18c102f5b125eec892fc5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.54e-04 | 140 | 14 | 2 | e64f6aa57bc069cfe970089bd1c298433bfaf771 | |
| ToppCell | P03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.66e-04 | 141 | 14 | 2 | 4a856521520ea73291f4730fe94c5de88c2b6f0c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-04 | 145 | 14 | 2 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.40e-04 | 147 | 14 | 2 | e99197e3c2e9d63153cc55ae62b30b8363c2267e | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.53e-04 | 148 | 14 | 2 | 3f48f5ba0a0928ddf6da7a1be1976933921f42ad | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-04 | 150 | 14 | 2 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.00e-03 | 152 | 14 | 2 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-03 | 152 | 14 | 2 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-03 | 152 | 14 | 2 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.00e-03 | 152 | 14 | 2 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-03 | 153 | 14 | 2 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Control-Myeloid-Neutrophils-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-03 | 153 | 14 | 2 | e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd | |
| ToppCell | Control-Myeloid-Neutrophils|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-03 | 153 | 14 | 2 | c33d63b2d1a220bc428e776b157b23faa43ea8ca | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 153 | 14 | 2 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-03 | 155 | 14 | 2 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-03 | 155 | 14 | 2 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-03 | 155 | 14 | 2 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 156 | 14 | 2 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-03 | 157 | 14 | 2 | 904cd98ae85ed6459e0663f077ac462842bf12df | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.07e-03 | 157 | 14 | 2 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | E15.5-Hematopoietic-Immune-immune_cell_unspecified|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-03 | 157 | 14 | 2 | 4263627911657e788a1d0230690ee434e8a4f9a1 | |
| ToppCell | E15.5-Hematopoietic-Immune|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-03 | 157 | 14 | 2 | de689a133863ed74d848eba0a4f392357ac28245 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.07e-03 | 157 | 14 | 2 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-03 | 158 | 14 | 2 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-03 | 158 | 14 | 2 | 78a8a498a9c84ed65e0eefaac781d5247c5b477a | |
| ToppCell | Hippocampus-Endothelial-MURAL|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 158 | 14 | 2 | 2d73b5e59c650c603fec6223b1c51f0962f7bc81 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-03 | 158 | 14 | 2 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-03 | 158 | 14 | 2 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 158 | 14 | 2 | ad1040bce6ad655c2502d9abb02507ecff177f83 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 158 | 14 | 2 | ac7aef01eda1dca80d6c5b508649fcad55803a67 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 158 | 14 | 2 | 7f4a644534b78f7e7539cae1fd895dad6f96862b | |
| ToppCell | E17.5-Hematopoietic|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-03 | 159 | 14 | 2 | a5648f731f1a22d1af1be2b0e1b80e29d05bae04 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.10e-03 | 159 | 14 | 2 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-03 | 160 | 14 | 2 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-03 | 160 | 14 | 2 | 86fde32f096eaf9ea3677f57169cdcc0a57bb8dd | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-03 | 160 | 14 | 2 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | E12.5-Hematopoietic-Immune|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-03 | 160 | 14 | 2 | cd59830a524c14a1f591c5c615b55510e4104e5b | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-03 | 160 | 14 | 2 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-03 | 160 | 14 | 2 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | E12.5-Hematopoietic-Immune-immune_cell_unspecified|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-03 | 160 | 14 | 2 | 5a4a5a50dfdf6af9406e4f685712f7fe390a02f3 | |
| ToppCell | E17.5-Hematopoietic-Immune|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-03 | 161 | 14 | 2 | e3ff08d0b9c686253556c56ee88648206751ef2b | |
| ToppCell | E17.5-Hematopoietic-Immune-immune_cell_unspecified|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-03 | 161 | 14 | 2 | 30741ca6548db2dfb5cf1faecf0d7412c91d0077 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-03 | 161 | 14 | 2 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-03 | 162 | 14 | 2 | ded08da888d8c481f0f96d1e0bfd03d617966910 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-03 | 164 | 14 | 2 | 9eed945e9b0c1ee5fc62724ac2bbbed4267b0678 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 164 | 14 | 2 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-03 | 164 | 14 | 2 | f510f20e37e31b486cdd0e3f597ce4ff00877c5d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 164 | 14 | 2 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | primary_visual_cortex-Non-neuronal-smooth_muscle_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-03 | 164 | 14 | 2 | 5c932a462cbf81d029c8d11ec3aea3191529527b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-03 | 164 | 14 | 2 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.17e-03 | 164 | 14 | 2 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| Drug | BAY61-3606 | 4.62e-06 | 5 | 16 | 2 | CID010200390 | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 8.76e-06 | 195 | 16 | 4 | 2122_DN | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 8.94e-06 | 196 | 16 | 4 | 5523_DN | |
| Drug | ER-27319 | 1.66e-05 | 9 | 16 | 2 | CID009799508 | |
| Drug | terreic acid | 2.08e-05 | 10 | 16 | 2 | CID000091437 | |
| Drug | FF 3 | 2.08e-05 | 10 | 16 | 2 | CID009543502 | |
| Drug | link Er | 1.27e-04 | 24 | 16 | 2 | CID000627503 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.52e-04 | 180 | 16 | 3 | 5223_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 2.73e-04 | 185 | 16 | 3 | 6965_DN | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 2.87e-04 | 188 | 16 | 3 | 974_UP | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.96e-04 | 190 | 16 | 3 | 2619_DN | |
| Drug | Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A | 2.96e-04 | 190 | 16 | 3 | 6555_UP | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.00e-04 | 191 | 16 | 3 | 4217_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.05e-04 | 192 | 16 | 3 | 6207_DN | |
| Drug | Niclosamide [50-65-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.10e-04 | 193 | 16 | 3 | 4136_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 3.10e-04 | 193 | 16 | 3 | 6946_DN | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 16 | 3 | 7032_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 16 | 3 | 6779_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 16 | 3 | 6955_UP | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 4947_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 7327_DN | |
| Drug | ST021200; Up 200; 10uM; MCF7; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 7554_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; HL60; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 1851_DN | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 2737_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 6988_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 7552_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 5757_UP | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 2090_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2514_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 6222_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 3444_DN | |
| Drug | Napelline [5008-52-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 6824_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2269_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5343_DN | |
| Drug | Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5785_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 4761_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 3995_DN | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 3.29e-04 | 197 | 16 | 3 | 959_UP | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 7551_UP | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5675_DN | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 6212_DN | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 7437_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A | 3.34e-04 | 198 | 16 | 3 | 762_UP | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6208_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 7008_UP | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 5529_DN | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 7430_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 7017_UP | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; HL60; HG-U133A | 3.39e-04 | 199 | 16 | 3 | 1782_DN | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4357_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6492_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 7348_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 7129_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 5516_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 4959_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 2652_DN | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 6484_DN | |
| Drug | tb-E | 4.91e-04 | 47 | 16 | 2 | CID000006588 | |
| Drug | N-Formylmethionine Leucyl-Phenylalanine | 5.79e-04 | 51 | 16 | 2 | ctd:D009240 | |
| Disease | stomach cancer (is_marker_for) | 3.82e-05 | 142 | 14 | 3 | DOID:10534 (is_marker_for) | |
| Disease | Medullomyoblastoma | 1.87e-04 | 43 | 14 | 2 | C0205833 | |
| Disease | Adult Medulloblastoma | 1.87e-04 | 43 | 14 | 2 | C0278876 | |
| Disease | Childhood Medulloblastoma | 1.87e-04 | 43 | 14 | 2 | C0278510 | |
| Disease | Desmoplastic Medulloblastoma | 1.87e-04 | 43 | 14 | 2 | C0751291 | |
| Disease | Melanotic medulloblastoma | 1.87e-04 | 43 | 14 | 2 | C1275668 | |
| Disease | Medulloblastoma | 2.53e-04 | 50 | 14 | 2 | C0025149 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.52e-04 | 301 | 14 | 3 | DOID:684 (is_marker_for) | |
| Disease | platelet measurement | 4.02e-04 | 315 | 14 | 3 | EFO_0005036 | |
| Disease | mean platelet volume | 1.08e-03 | 1020 | 14 | 4 | EFO_0004584 | |
| Disease | immature platelet fraction | 1.31e-03 | 114 | 14 | 2 | EFO_0009187 | |
| Disease | immature platelet measurement | 1.42e-03 | 119 | 14 | 2 | EFO_0803541 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.52e-03 | 670 | 14 | 3 | EFO_0006335, EFO_0006336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKSKPPPTYESEEED | 591 | O60885 | |
| PDSPYKVCMVPMETS | 471 | Q9NZU0 | |
| QRPKTPPTDTTMYME | 316 | Q8N109 | |
| PMAPTTYDPMLKVDD | 381 | Q16832 | |
| QRPKTPPTDTTMYME | 316 | Q8NHK3 | |
| ESMRTEKYDPMPPES | 1041 | P16885 | |
| MEVFEYTRPMMHPEP | 201 | Q86XK2 | |
| MLDMFKRPTDPPEYN | 581 | Q13423 | |
| MESLKTDTEMPYPEV | 1 | P0C7P3 | |
| ADPEMPKRMYIHPDS | 176 | O15119 | |
| NEMTTPSLDYSMPAP | 581 | Q8TE76 | |
| EMPKRMYIHPDSPAT | 181 | Q13207 | |
| EPVSMPPKMTEYDKR | 181 | P15498 | |
| MEKPSRPMESNPDTE | 526 | P49190 | |
| MDASEEPLPPVIYTM | 1 | P48553 | |
| VEYPDMPRSLPSHME | 1716 | Q5THJ4 |